Similar articles for PMID: 33741643

Year	Number of Results
2002	1
2004	1
2005	2
2007	3
2008	2
2010	1
2011	2
2012	7
2013	8
2014	7
2015	9
2016	13
2017	11
2018	13
2019	10
2020	10
2021	15
2022	14
2023	2
2024	0

1

Dose-Response and Dose-Toxicity Relationships for Glass ⁹⁰Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer.

Alsultan AA, van Roekel C, Barentsz MW, Smits MLJ, Kunnen B, Koopman M, Braat AJAT, Bruijnen RCG, de Keizer B, Lam MGEH. Alsultan AA, et al. J Nucl Med. 2021 Nov;62(11):1616-1623. doi: 10.2967/jnumed.120.255745. Epub 2021 Mar 19. J Nucl Med. 2021. PMID: 33741643 Free PMC article.

2

Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.

van den Hoven AF, Rosenbaum CE, Elias SG, de Jong HW, Koopman M, Verkooijen HM, Alavi A, van den Bosch MA, Lam MG. van den Hoven AF, et al. J Nucl Med. 2016 Jul;57(7):1014-9. doi: 10.2967/jnumed.115.166942. Epub 2016 Feb 23. J Nucl Med. 2016. PMID: 26912436 Free article. Clinical Trial.

3

Dose-Effect Relationships of ¹⁶⁶Ho Radioembolization in Colorectal Cancer.

van Roekel C, Bastiaannet R, Smits MLJ, Bruijnen RC, Braat AJAT, de Jong HWAM, Elias SG, Lam MGEH. van Roekel C, et al. J Nucl Med. 2021 Feb;62(2):272-279. doi: 10.2967/jnumed.120.243832. Epub 2020 Jun 26. J Nucl Med. 2021. PMID: 32591491 Free article.

4

First Evidence for a Dose-Response Relationship in Patients Treated with ¹⁶⁶Ho Radioembolization: A Prospective Study.

Bastiaannet R, van Roekel C, Smits MLJ, Elias SG, van Amsterdam WAC, Doan D, Prince JF, Bruijnen RCG, de Jong HWAM, Lam MGEH. Bastiaannet R, et al. J Nucl Med. 2020 Apr;61(4):608-612. doi: 10.2967/jnumed.119.232751. Epub 2019 Oct 10. J Nucl Med. 2020. PMID: 31601696 Free article. Clinical Trial.

5

Dose-response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases.

Ebbers SC, van Roekel C, Braat MNGJA, Barentsz MW, Lam MGEH, Braat AJAT. Ebbers SC, et al. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1700-1710. doi: 10.1007/s00259-021-05642-3. Epub 2021 Dec 7. Eur J Nucl Med Mol Imaging. 2022. PMID: 34873638

6

Prediction of Tumor Control in ⁹⁰Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics.

Dewaraja YK, Devasia T, Kaza RK, Mikell JK, Owen D, Roberson PL, Schipper MJ. Dewaraja YK, et al. J Nucl Med. 2020 Jan;61(1):104-111. doi: 10.2967/jnumed.119.226472. Epub 2019 May 30. J Nucl Med. 2020. PMID: 31147404 Free PMC article.

7

Radioembolization with ⁹⁰Y glass microspheres for hepatocellular carcinoma: significance of pretreatment ¹¹C-acetate and ¹⁸F-FDG PET/CT and posttreatment ⁹⁰Y PET/CT in individualized dose prescription.

Ho CL, Chen S, Cheung SK, Leung YL, Cheng KC, Wong KN, Wong YH, Leung TWT. Ho CL, et al. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2110-2121. doi: 10.1007/s00259-018-4064-6. Epub 2018 Jun 11. Eur J Nucl Med Mol Imaging. 2018. PMID: 29948107

8

Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.

Garin E, Rolland Y, Edeline J, Icard N, Lenoir L, Laffont S, Mesbah H, Breton M, Sulpice L, Boudjema K, Rohou T, Raoul JL, Clement B, Boucher E. Garin E, et al. J Nucl Med. 2015 Mar;56(3):339-46. doi: 10.2967/jnumed.114.145177. Epub 2015 Feb 12. J Nucl Med. 2015. PMID: 25678490 Free article.

9

Hepatocellular Carcinoma Tumor Dose Response After ⁹⁰Y-radioembolization With Glass Microspheres Using ⁹⁰Y-SPECT/CT-Based Voxel Dosimetry.

Kappadath SC, Mikell J, Balagopal A, Baladandayuthapani V, Kaseb A, Mahvash A. Kappadath SC, et al. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):451-461. doi: 10.1016/j.ijrobp.2018.05.062. Epub 2018 Jun 2. Int J Radiat Oncol Biol Phys. 2018. PMID: 30191875

10

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, Gonen M, Ziv E, Boas FE, Sofocleous CT. Shady W, et al. Eur J Radiol. 2016 Jun;85(6):1224-31. doi: 10.1016/j.ejrad.2016.03.029. Epub 2016 Mar 31. Eur J Radiol. 2016. PMID: 27161074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year